ARCHIVES

Research Needed On Hormonally Active Agents, Report Finds

This article is from The Cancer Letter archive.

Vol. 25 No. 31 | August 6, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Friends Of Cancer Research Plan September Launch

August 9, 1996

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

June 12, 1981

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982